What we're reading, March 30, 2016: the Supreme Court asks for more information in birth control case; Americans display lack of knowledge about Zika virus; and China provides an opportunity for drugs that fail to make it to market elsewhere.
With only 8 sitting members on the Supreme Court, the judges appear deadlocked on an important case on contraception access. Kaiser Health News reported that the court has asked lawyers involved in the case to provide more information on how women working for religious employers may access birth control. The judges had seemed evenly divided after arguments last week, and the court is also asking the lawyers to provide a possible compromise in the case.
Although Americans recognize that the Zika virus is spreading and could reach the continental US, they are unaware of the basic facts of the virus. While a large majority of people realize the virus is spread by mosquitoes, one-third also believe Zika can be spread by coughing or sneezing, according to USA Today. In addition, nearly one-fourth of adults in households where someone is pregnant or considering becoming pregnant didn’t know about the link between Zika and microcephaly.
China is providing a second life for some drugs that don’t make it to market elsewhere in the world. Companies licensing drugs to Chinese startups after a treatment fails to outperform other drugs is becoming a new trend, reported The Wall Street Journal. However, it isn’t unusual or unlawful for companies to get a drug approved in one jurisdiction but not another, and in China companies don’t have to prove a drug’s superiority over existing treatments.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More